» Articles » PMID: 18242604

Impact of Hospital Volume on Postoperative Morbidity and Mortality Following a Colectomy for Ulcerative Colitis

Overview
Specialty Gastroenterology
Date 2008 Feb 5
PMID 18242604
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: Postoperative morbidity and mortality following a colectomy for ulcerative colitis (UC) has been primarily reported from tertiary care referral centers that perform a high volume of operations; however, the postoperative outcomes among nonselected hospitals are not known. We set out to evaluate postoperative morbidity and mortality using a nationally representative database and to determine the factors that influenced outcomes.

Methods: We analyzed the 1995-2005 Nationwide Inpatient Sample to identify 7108 discharges for UC patients who underwent a total abdominal colectomy. The effects of hospital volume on postoperative morbidity and mortality were evaluated in logistic regression models adjusting for demographic and clinical factors.

Results: Postoperative mortality and morbidity rates were 2.3% and 30.8%, respectively. Most operations were performed in low-volume hospitals that had an increased risk of death (adjusted odds ratio [aOR], 2.42; 95% confidence interval [CI]: 1.26-4.63). In-hospital mortality was increased in patients who were admitted emergently (aOR, 5.40; 95% CI: 3.48-8.40), aged 60-80 years (aOR, 8.70; 95% CI: 3.30-22.92), and those with Medicaid (aOR, 4.29; 95% CI: 2.13-8.66). Emergently admitted UC patients whose surgery was performed 6 days after their admission had significantly increased likelihood of in-hospital death (aOR, 2.12; 95% CI: 1.13-3.97).

Conclusions: Postoperative mortality was lowest in hospitals that performed the highest volume of operations. Increasing the proportion of total colectomies performed in high-volume hospitals may improve clinical outcomes for patients with UC.

Citing Articles

The fate of the rectum in ulcerative colitis at index surgery and beyond-a contemporary cohort.

Stephens I, Murphy B, McCawley N, McNamara D, Burke J Int J Colorectal Dis. 2025; 40(1):12.

PMID: 39808215 PMC: 11732862. DOI: 10.1007/s00384-024-04779-5.


Characterization of Inflammatory Bowel Disease in the Elderly According to Age of Onset.

Gonzalez M, Olmedo Martin R, Morales Bermudez A, Jimenez Perez M J Clin Med. 2025; 13(24.

PMID: 39768503 PMC: 11728034. DOI: 10.3390/jcm13247581.


Panduratin A mitigates inflammation and oxidative stress in DSS-induced colitis mice model.

Alqudah A, Qnais E, Gammoh O, Bseiso Y, Wedyan M, Oqal M Future Sci OA. 2024; 10(1):2428129.

PMID: 39559852 PMC: 11581177. DOI: 10.1080/20565623.2024.2428129.


Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium.

Dulai P, Bonner L, Sadler C, Raffals L, Kochhar G, Lindholm P Aliment Pharmacol Ther. 2024; 60(11-12):1512-1524.

PMID: 39403018 PMC: 11599782. DOI: 10.1111/apt.18326.


Close outpatient follow-up associated with reduced readmission rates in patients with inflammatory bowel disease.

Tran P, Tjahja M, Wang Y, Seth N, Reyes R, Bussell C Proc (Bayl Univ Med Cent). 2024; 37(4):517-524.

PMID: 38910831 PMC: 11188799. DOI: 10.1080/08998280.2024.2335095.